|
1
|
World Health Organization, . India-Cancer
Country Profile. 2014.
|
|
2
|
Stewart BW and Wild CP: World cancer
report 2014. World Heal Organ. 1–2. 2014.
|
|
3
|
American Cancer Society, . Cancer Facts
& Figures. Atlanta, USA: 2015
|
|
4
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-Update. Nucleic Acids Res. 41(Database Issue):
D991–D995. 2013.PubMed/NCBI
|
|
5
|
Kolesnikov N, Hastings E, Keays M,
Melnichuk O, Tang YA, Williams E, Dylag M, Kurbatova N, Brandizi M,
Burdett T, et al: ArrayExpress update-simplifying data submissions.
Nucleic Acids Res. 43(Database Issue): D1113–D1116. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Hou R, Niu X, Liu R, Wang Q, Wang C,
Li X, Hao Z, Yin G and Zhang K: Comparison of microarray and
RNA-Seq analysis of mRNA expression in dermal mesenchymal stem
cells. Biotechnol Lett. 38:33–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fumagalli D, Blanchet-Cohen A, Brown D,
Desmedt C, Gacquer D, Michiels S, Rothé F, Majjaj S, Salgado R,
Larsimont D, et al: Transfer of clinically relevant gene expression
signatures in breast cancer: From Affymetrix microarray to Illumina
RNA-Sequencing technology. BMC Genomics. 15:10082014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao S, Fung-Leung WP, Bittner A, Ngo K
and Liu X: Comparison of RNA-Seq and microarray in transcriptome
profiling of activated T cells. PLoS One. 9:e786442014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X, Bentink S and Spang R: Detecting
common gene expression patterns in multiple cancer outcome
entities. Biomed Microdevices. 7:247–251. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:pp. 9309–9314. 2004;
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Geman D and Winslow RL: Large-scale
integration of cancer microarray data identifies a robust common
cancer signature. BMC Bioinformatics. 8:2752007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao P, Hu W, Wang H, Yu S, Li C, Bai J,
Gui S and Zhang Y: Identification of differentially expressed genes
in pituitary adenomas by integrating analysis of microarray data.
Int J Endocrinol. 2015:1640872015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Z, Chen Y, Fu Y, Yang Y, Zhang Y,
Chen Y and Li D: Meta-analysis of differentially expressed genes in
osteosarcoma based on gene expression data. BMC Med Genet.
15:802014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan SK, Griffith OL, Tai IT and Jones SJ:
Meta-analysis of colorectal cancer gene expression profiling
studies identifies consistently reported candidate biomarkers.
Cancer Epidemiol Biomarkers Prev. 17:543–552. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dopazo J: Functional profiling methods in
cancer. Methods Mol Biol. 576:363–374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Griffith OL, Melck A, Jones SJ and Wiseman
SM: Meta-analysis and meta-review of thyroid cancer gene expression
profiling studies identifies important diagnostic biomarkers. J
Clin Oncol. 24:5043–5051. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tabas-Madrid D, Nogales-Cadenas R and
Pascual-Montano A: GeneCodis3: A non-redundant and modular
enrichment analysis tool for functional genomics. Nucleic Acids
Res. 40(Web Server Issue): W478–W483. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated. Genome Biol. 4:P32003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
S.J. C: Home Page|Cancer Genetics Web.
|
|
20
|
McKusick VA: McKusick-Nathans Institute
for Genetic Medicine, Johns Hopkins University. National Center for
Biotechnology Information, National Library of Medicine B:
Home-OMIM-NCBI. 2004.
|
|
21
|
Wu CC, D'Argenio D, Asgharzadeh S and
Triche T: TARGETgene: A tool for identification of potential
therapeutic targets in cancer. PLoS One. 7:e433052012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gruosso T, Mieulet V, Cardon M, Bourachot
B, Kieffer Y, Devun F, Dubois T, Dutreix M, Vincent-Salomon A,
Miller KM and Mechta-Grigoriou F: Chronic oxidative stress promotes
H2AX protein degradation and enhances chemosensitivity in breast
cancer patients. EMBO Mol Med. 8:527–549. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Timmerman LA, Holton T, Yuneva M, Louie
RJ, Padró M, Daemen A, Hu M, Chan DA, Ethier SP, van't Veer LJ, et
al: Glutamine sensitivity analysis identifies the xct antiporter as
a common triple-negative breast tumor therapeutic target. Cancer
Cell. 24:450–465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu T, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arredouani MS, Lu B, Bhasin M, Eljanne M,
Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA and
Sanda MG: Identification of the transcription factor single-minded
Homologue 2 as a potential biomarker and immunotherapy target in
prostate cancer. Clin Cancer Res. 15:5794–5802. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Planche A, Bacac M, Provero P, Fusco C,
Delorenzi M, Stehle JC and Stamenkovic I: Identification of
prognostic molecular features in the reactive stroma of human
breast and prostate cancer. PLoS One. 6:e186402011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rahman M, Jackson LK, Johnson WE, Li DY,
Bild AH and Piccolo SR: Alternative preprocessing of RNA-Sequencing
data in the cancer genome atlas leads to improved analysis results.
Bioinformatics. 31:3666–3672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jeanmougin M, de Reynies A, Marisa L,
Paccard C, Nuel G and Guedj M: Should we abandon the t-Test in the
analysis of gene expression microarray data: A comparison of
variance modeling strategies. PLoS One. 5:e123362010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Law CW, Chen Y, Shi W and Smyth GK: Voom:
Precision weights unlock linear model analysis tools for RNA-seq
read counts. Genome Biol. 15:R292014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pathak M, Dwivedi SN, Deo SVS, Sreenivas V
and Thakur B: Which is the preferred measure of heterogeneity in
meta-analysis and why? A revisit. Biostat Biometrics. 2017.
|
|
37
|
Schwarzer G: Package ‘meta. ’ R News:.
7:40–45. 2007.
|
|
38
|
Ramasamy A, Mondry A, Holmes CC and Altman
DG: Key issues in conducting a meta-analysis of gene expression
microarray datasets. PLoS Med. 5:e1842008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamada Y, Toyota M, Hirokawa Y, Suzuki H,
Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T and
Watanabe M: Identification of differentially methylated CpG islands
in prostate cancer. Int J Cancer. 112:840–845. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Faltermeier CM, Drake JM, Clark PM, Smith
BA, Zong Y, Volpe C, Mathis C, Morrissey C, Castor B, Huang J and
Witte ON: Functional screen identifies kinases driving prostate
cancer visceral and bone metastasis. Proc Natl Acad Sci USA.
113:pp. E172–E181. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kamalian L, Gosney JR, Forootan SS, Foster
CS, Bao ZZ, Beesley C and Ke Y: Increased expression of Id family
proteins in small cell lung cancer and its prognostic significance.
Clin Cancer Res. 14:2318–2325. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen D and Yang H: Integrated analysis of
differentially expressed genes in breast cancer pathogenesis. Oncol
Lett. 9:2560–2566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao Y, Fu D, Xu C, Yang J and Wang Z:
Identification of genes associated with tongue cancer in patients
with a history of tobacco and/or alcohol use. Oncol Lett.
13:629–638. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang Y, Tao Y, Li X, Chang S, Jiang B, Li
F and Wang Z: Bioinformatics analysis of key genes and latent
pathway interactions based on the anaplastic thyroid carcinoma gene
expression profile. Oncol Lett. 13:167–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
